CellFE
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Atlantic Ave 104, Alameda, Californ...Phone Number
(267) 663-1898Website
www.cellfebiotech.comRevenue
<$5 MillionIndustry
About CellFE
CellFE Org Chart
Is CellFE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CellFE has new funding data
CellFE, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CellFE had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CellFE
Earning: See what the market has to say on CellFE recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if CellFE is spiking on competitors!
Product Launch: Get notified when CellFE launches new products
Check if CellFE has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to CellFE
Compare insights from companies similar to CellFE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CellFE is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CellFE is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CellFE.
CellFE financials insights
Gather financial insights about CellFE, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$22M
CellFE Tech Stack
A closer look at the technologies used by CellFE
Most Recent Scoops
CellFE News & Media
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ -- CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to...CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies
Proprietary Next-Generation Non-Viral, Non-Electroporative Transfection Platform Gaining Traction in Cell Therapy Market ALAMEDA, Calif., Dec. 19, 2024 /PRNewswire/ -- CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools,...CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
Non-Viral Cell Therapy Manufacturing System Enables Faster Development Time and Healthier Cells vs. Electroporation ALAMEDA, Calif., June 25, 2024 /PRNewswire/ -- CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy...CellFE Announces Presentations at Upcoming International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting
ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy manufacturing, announced today an upcoming presentation by CEO Alla Zamarayeva, PhD, at the International Society of Gene & Cell...
Top Business Services Companies
Frequently Asked Questions Regarding CellFE
CellFE specializes in transforming the manufacturing of cell therapies through innovative microfluidic-based gene editing technology. Their products, including the Ryva Mechanoporation System, are designed for researchers and developers in the cell therapy field, enabling affordable and efficient treatments. The company aims to enhance access to li... Read More